Searchable abstracts of presentations at key conferences in endocrinology

ea0014p572 | (1) | ECE2007

Impairment of GH secretion by ghrelin stimulation test in primary hyperparathyroidism (PHP)

Cecconi Elisabetta , Giovannetti Clara , Manetti Luca , Raffaelli Valentina , Procopio Massimo , Ghigo Ezio , Gasperi Maurizio , Martino Enio

Pituitary GH secretion is regulated by the interplay of at least two hypothalamic hormones, GH-releasing hormone (GHRH) and somatostatin, through their interaction with specific cell surface receptors on the anterior pituitary somatotrophs. A third type of receptor, the growth hormone secretagogue receptor, called GHS receptor type 1a (GHSR1a), was identified in the pituitary and the hypothalamus. Ghrelin is an acylated peptide produced predominantly by stomach and a natural l...

ea0011p23 | Bone | ECE2006

The reduction of bone mineral density in post-menopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH hormone secretion impairment

Cecconi E , Genovesi M , Bogazzi F , Grasso L , Procopio M , Marcocci C , Pinchera A , Bartalena L , Martino E , Gasperi M

Primary hyperparathyroidism (PHP) and growth hormone deficiency (GHD) are both associated with alterations of bone metabolism.GH secretion is frequently impaired in PHP patients; thus GH/IGF-I system alterations could be involved in the pathogenesis of osteoporosis.In the present study 50 post-menopausal women with PHP were evaluated by GH response to GH-releasing hormone (GHRH)+arginine (ARG) test and femoral neck bone mineral den...

ea0090p281 | Adrenal and Cardiovascular Endocrinology | ECE2023

The cardiometabolic risk in patients with non-functioning adrenal incidentaloma: an observational, retrospective and propensity score matched study

Parasiliti Caprino Mirko , Bioletto Fabio , Tomaiuolo Gabriella , Roux Anna , Lopez Chiara , Bollati Martina , Procopio Matteo , Arata Stefano , Ghigo Ezio , Arvat Emanuela , GIORDANO Roberta , Maccario Mauro

Introduction: Recent studies found an increased cardiometabolic risk in patients with Non-Functioning Adrenal Incidentaloma (NFAI), but all these data have low quality of evidence.Objective: To establish whether cardiometabolic risk and complications in NFAI patients can be associated to the presence of a non-secreting adrenal tumor, independently from potential confounding factors.Subjects and Methods: In this cross-sectional and ...

ea0090p285 | Adrenal and Cardiovascular Endocrinology | ECE2023

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension

Bioletto Fabio , Lopez Chiara , Bollati Martina , Arata Stefano , Procopio Matteo , Ponzetto Federico , Beccuti Guglielmo , Mengozzi Giulio , Ghigo Ezio , Maccario Mauro , Parasiliti Caprino Mirko

Background: The systematic use of confirmatory tests in the diagnosis of primary aldosteronism (PA) increases costs, risks and complexity to the diagnostic work-up. In light of this, some authors proposed aldosterone-to-renin (ARR) cut-offs and/or integrated flow-charts to avoid this step. Patients with resistant hypertension (RH), however, are characterized by a dysregulated renin-angiotensin-aldosterone system, even in the absence of PA. Thus, it is unclear whether those str...

ea0070aep206 | Bone and Calcium | ECE2020

Parathyroid carcinoma: An italian multicenter retrospective analysis

Gianotti Laura , Castellano Elena , Lauro Corrado , Piovesan Alessandro , Procopio Massimo , Barale Marco , Palestini Nicola , Quaglino Francesco , Manfrino Luca , Bullara Valentina , Volante Marco , Borretta Giorgio

Parathyroid carcinoma (PC) is a rare neoplasia responsible for about 1% of primary hyperparathyroidism (PHPT). Differently from patients with its benign counterpart, the phenotype of these patients is characterized by severe PHPT and hypercalcemia. The aim of this study was to describe a series of PC casesrecorded in the regional cancer network of Piedmont and Valle d’Aosta, Italy (Rete Oncologica del Piemonte e della Valle d’Aosta) from 2007 to 2017, including 25 ...

ea0070aep562 | Pituitary and Neuroendocrinology | ECE2020

Treatment of acromegalic osteopathy in the real-life clinical practice: The baac (bone active drugs in acromegaly) multicenter study

Mazziotti Gherardo , Battista Claudia , Chiloiro Sabrina , Maffezzoni Filippo , Ferrante Emanuele , Grottoli Silvia , Grasso Ludovica , Gatto Federico , Olivetti Roberto , Arosio Maura , Bianchi Antonio , Carosi Giulia , Cellini Miriam , Chiodini Iacopo , De Marinis Laura , Di Somma Carolina , Ferlin Alberto , Ghigo Ezio , Lavezzi Elisabetta , Mantovani Giovanna , Pivonello Rosario , Porcelli Teresa , Prencipe Nunzia , Procopio Massimo , Scillitani Alfredo , Lania Andrea

Osteopathy is an emerging complication of acromegaly, characterized by increased bone turnover, profound abnormalities in trabecular bone structure and high risk of vertebral fractures (VFs). The therapeutic management of skeletal fragility in acromegaly is a challenge, since the risk of fractures may remain high after the control of acromegaly and the effectiveness of bone-active drugs in this clinical setting is unknown. In this retrospective-multicenter study, we aimed at e...